Abstract
BACKGROUND—Ocular damage in leprosy is due either to nerve damage or infiltration by mycobacteria. There is currently little information about the magnitude and nature of incident ocular pathology in cured leprosy patients. This information would increase our understanding of the pathophysiology of ocular involvement in leprosy and help in developing programmes to address the eyecare needs of leprosy patients who have been released from treatment. The cumulative incidence of leprosy related ocular pathology and cataract was measured during an 11 year follow up period in cured leprosy patients released from treatment in Korea. METHODS—In 1988 standardised eye examinations were performed on 501 patients in eight resettlement villages in central South Korea. In May 1999 standardised eye examinations were repeated in this population. RESULTS—Among the patients in whom there was no sight threatening leprosy related ocular disease (lagophthalmos, posterior synechia, or keratitis) in 1988, 14.7% developed one or more of these conditions. Overall, among those with no vision reducing cataract in 1988, 26.4% had developed a vision reducing lens opacity in at least one eye. Among patients examined in both 1988 and 1999, 14.3% developed visual impairment and 5.7% developed blindness. CONCLUSION—This study demonstrates that leprosy related ocular pathology progresses in some patients even after they are cured mycobiologically. The progressive leprosy related lesions are the result of chronic nerve damage; ocular lesions due to infiltration by Mycobacterium leprae did not develop. Based on the factors found to be associated with development of the most visually significant findings (posterior synechia, keratitis, and cataract) certain patients should be targeted at discharge for active follow up eye care. We suggest that patients with lagophthalmos (even in gentle closure), trichiasis, small pupils, and posterior synechiae should be screened regularly for the development of lagophthalmos in forced closure, keratitis, and cataract.
Full Text
The Full Text of this article is available as a PDF (115.4 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Courtright P., Kim S. H., Lee H. S., Lewallen S. Excess mortality associated with blindness in leprosy patients in Korea. Lepr Rev. 1997 Dec;68(4):326–330. doi: 10.5935/0305-7518.19970040. [DOI] [PubMed] [Google Scholar]
- Courtright P., Lee H. S., Lewallen S. Training for primary eye care in leprosy. Bull World Health Organ. 1990;68(3):347–351. [PMC free article] [PubMed] [Google Scholar]
- Courtright P., Lewallen S., Lee H. S. Comparison of the old and new W.H.O. leprosy disability grading scheme for ocular disabilities. Int Ophthalmol. 1991 Sep;15(5):295–298. doi: 10.1007/BF00128946. [DOI] [PubMed] [Google Scholar]
- Guimarães F. C., Cruz A. A. Eyelid changes in long-standing leprosy. Ophthal Plast Reconstr Surg. 1998 Jul;14(4):239–243. doi: 10.1097/00002341-199807000-00003. [DOI] [PubMed] [Google Scholar]
- Hogeweg M., Faber W. R. Progression of eye lesions in leprosy: ten-year follow-up study in The Netherlands. Int J Lepr Other Mycobact Dis. 1991 Sep;59(3):392–397. [PubMed] [Google Scholar]
- Lewallen S., Courtright P., Lee H. S. Ocular autonomic dysfunction and intraocular pressure in leprosy. Br J Ophthalmol. 1989 Dec;73(12):946–949. doi: 10.1136/bjo.73.12.946. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Waddell K. M., Saunderson P. R. Is leprosy blindness avoidable? The effect of disease type, duration, and treatment on eye damage from leprosy in Uganda. Br J Ophthalmol. 1995 Mar;79(3):250–256. doi: 10.1136/bjo.79.3.250. [DOI] [PMC free article] [PubMed] [Google Scholar]